Reported Earlier, MAIA Biotechnology Raises $30M Through 20M Common Share Public Offering At $1.50 Per Share To Fund Cancer Immunotherapy Clinical Trials
MAIA Biotechnology, Inc. +0.74% Pre
MAIA Biotechnology, Inc. MAIA | 1.37 1.37 | +0.74% 0.00% Pre |
Reported Earlier, MAIA Biotechnology Raises $30M Through 20M Common Share Public Offering At $1.50 Per Share To Fund Cancer Immunotherapy Clinical Trials
